News

All ISHLT members are invited to join Society leaders and fellow members for the ISHLT 2025 Annual Business Meeting—a chance to hear key updates and discuss issues of interest to the ISHLT community on Wednesday 21, May.

Final Day of ISHLT2025

During the final General Session of the ISHLT’s 45th Annual Meeting & Scientific Sessions, ISHLT recognized outstanding achievements in research and groundbreaking scientific contributions.

Tuesday at ISHLT2025

At the ISHLT Annual Meeting in Boston, Dr. Jeffrey Teuteberg showed how molecular testing like cell-free DNA is reducing biopsies, personalizing post-transplant care, and improving outcomes through earlier rejection detection and easier remote monitoring.

Ready for Day Two of ISHLT2025?

At the ISHLT Annual Meeting in Boston, Jitte Jennekens shared that the HOPE technique safely preserves donor lungs outside the body for up to 20 hours. In a study of 12 HOPE cases, all lungs were successfully transplanted with outcomes matching traditional methods, showing promise for extended lung preservation.

At the ISHLT Annual Meeting in Boston, Dr. Angela Lorts stressed the need for pediatric-specific MCS devices, as current adult devices are used off-label for children, leading to safety concerns and supply issues. She introduced the ACTION Network to improve awareness and collaborate on better solutions.

Ten years after its introduction, heart donation after circulatory death (DCD) has significantly boosted transplant rates, with many centers reporting a 30% increase. Proven as effective as traditional methods, DCD is now widely adopted and continues to expand access to life-saving heart transplants.

A talk at the ISHLT2025 Annual Meeting given by Emily Granger, MBBS from St. Vincent’s Hospital in Sydney highlights how machine perfusion technology is revolutionizing heart transplantation in geographically vast countries like Australia.

A groundbreaking collaboration among leading organizations in pediatric heart transplantation has led to the formation of Pediatric Heart Transplant Alliance. Founding partners include Enduring Hearts, ISHLT, PHTS, Transplant Families, ACTION, and Additional Ventures.

At the Opening General Session of the ISHLT2025 Annual Meeting & Scientific Sessions in Boston, ISHLT President Christian Benden unveiled the Society’s new strategic plan.

Welcome to ISHLT2025!

At the ISHLT Annual Meeting, a dedicated ISHLT/ICA CTEPH conference spotlighted major advances in diagnosing and treating this often-misdiagnosed lung condition caused by chronic blood clots. Improved awareness and techniques are driving earlier detection and better outcomes.

Healthcare practitioners from around the world received hands-on training for treating patients in cardiogenic shock (CS) during a first-ever simulation lab at today’s Annual Meeting and Scientific Sessions of ISHLT in Boston.

The 2023 International Thoracic Organ Transplant (TTX) Registry Report is now available. This is a special report focuses on renal failure after thoracic organ transplantation.

Meet the ISHLT2025 Roving Reporters. These eight ISHLT members will be posting summaries and insights through ISHLT2025. Connect with them on social media to follow along!

First author Charlotte Van Edom of the University Hospitals Leuven in Belgium guests on JHLT: The Podcast to discuss apixaban in HeartMate 3 patients.

The ISHLT 45th Annual Meeting & Scientific Sessions is in just a few weeks! It’s not too late to join your global peers and colleagues for the latest multidisciplinary transplantation science.

Endorsed by ISHLT, this consensus-based framework represents the first of it's kind specific to both the content and process of the psychosocial evaluation for pediatric cardiothoracic transplantation/VAD.